TRG Latin America Acquisitions Corp. — Q3 2026 Form 10-Q
Reporting period: Three and nine months ended September 30, 2026; filed November 13, 2026. The unaudited company is a Cayman Islands SPAC formed to pursue a business combination. It had not begun operations or signed a definitive agreement with a target by quarter-end.
Financial performance and position
- Revenue: No operating revenue. The company expects none before completing a business combination.
- Net income (loss): Q3 net income was $1.81 million, compared with a $2.16 million net loss for the first nine months of 2026. Q3 income reflected $1.93 million of trust-account interest, offset by $123,000 of general and administrative costs. Nine-month results included $6.57 million of formation, general and administrative costs and $111,000 of share-based compensation, offset by $4.36 million of trust interest and a $167,000 gain from the change in fair value of the over-allotment option liability.
- Cash flow: Operating activities used $406,000 in the first nine months. Financing activities provided $207.83 million, principally IPO and private-placement proceeds; $206.32 million was invested in the trust account. Cash increased from zero at year-end 2025 to $1.11 million.
- Liquidity and assets: At September 30, cash outside the trust was $1.11 million, reported working capital was $1.04 million, trust investments were $210.68 million, and total assets were $211.92 million. Trust assets included $4.36 million of interest earned since the IPO.
- Debt and obligations: No working-capital loans or long-term debt were outstanding. Current liabilities were $174,000. The balance sheet also recorded a $6.19 million advisory fee payable and a $6.19 million deferred underwriting fee; the deferred fee is payable from trust funds only if a business combination is completed. The advisory fee is also tied to completion under the advisory agreement.
- Margins: Not meaningful because the company has no operating revenue.
Material changes and capital structure
- The IPO closed February 27, 2026, raising $200 million; a partial over-allotment exercise added $6.32 million. The sponsor separately purchased $2.25 million of private-placement units. A total of $206.32 million was placed in trust.
- Trust assets grew from zero at December 31, 2025, to $210.68 million at September 30, 2026, primarily reflecting IPO funding and investment income. There is no prior-year quarterly income comparison in the filing.
- At September 30, 20.632 million Class A shares were subject to possible redemption at approximately $10.21 per share; 225,000 additional Class A shares and 5.158 million Class B shares were outstanding. The remaining 592,000 forfeitable founder shares were forfeited in April 2026.
Outlook, risks and other matters
- The company has until February 27, 2028, or an earlier date set by its board, to complete a business combination, subject to any permitted extension. If it fails, it expects to redeem public shares and liquidate, subject to applicable law and creditor claims.
- Management says current funds should cover working-capital needs for one year from issuance of the financial statements, but cautions that higher-than-expected target-search, diligence or transaction costs could leave insufficient funds. Additional financing may be needed to complete a transaction or address substantial redemptions.
- Management is seeking targets consistent with its experience and prioritizes profitable businesses with sustainable growth and robust cash flow. No target has been identified in a definitive agreement, and no successful transaction is assured.
- Risks include market, economic, regulatory and geopolitical disruption; potential Nasdaq suspension or delisting if applicable SPAC timing requirements are not met; sponsor indemnity that may be difficult to collect; and possible dilution from founder-share conversion or financing. Public-share rights may expire worthless if no combination occurs, and post-combination shares may trade below the approximately $10.21 redemption value.
- Management reported effective disclosure controls as of September 30, 2026, with no material change in internal control over financial reporting. The filing reports no material pending or contemplated litigation and no material subsequent events requiring disclosure.
Key facts for investors to verify
- Whether a target has been identified or a transaction agreement signed since September 30, 2026, and whether the February 27, 2028 deadline remains unchanged.
- Current trust balance, redemption value per public share, and any trust withdrawals or redemptions after quarter-end.
- Terms, timing and payment conditions for the $6.19 million advisory fee and $6.19 million deferred underwriting fee.
- Available cash outside the trust, projected transaction-search costs, and any new sponsor loans or other financing.
- Potential dilution from rights, founder-share conversion, redemptions, or transaction-related securities issuance.